Pharma’s path to Net Zero: Targeting Scope 3 emissions

With a target of net zero for 2050, pharma companies need to tackle Scope 3 emissions, which make up the majority of their carbon footprint

Feature

Comment

The Big Interview

In Data

Leading innovators in aircraft air conditioning